Diabetes Drug Slows Experimental Parkinson’s Disease Progression.

Diabetes Drug Slows Experimental Parkinson’s Disease Progression.
GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of Parkinson’s disease (PD) following publication of research findings today in the journal Science Translational Medicine. “We hope this will be a watershed moment for millions of ... read more
Source: The Cure Parkinson’s TrustPublished on 2017-07-17